Active — Not RecruitingNot Applicable

Registry Study of Pregnancy and Breast Cancer

Spain866 participantsStarted 2019-11-18

Plain-language summary

An ambispective observational registry study of pregnancy and breast cancer

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The patient should have signed and dated the informed consent form (ICF). The enrollment of patients who have died is allowed.
✓. Women aged ≥ 18 years.
✓. Patients in one of the following situations:
✓. The patients referred to in the previous section and the patients who meet these characteristics prospectively could be enrolled retrospectively upon registry opening.
✓. All cases diagnosed at the same site may be included. In order to prevent duplications, in case the patient followed her treatment and follow-up at another site, she will be enrolled as per the site where the diagnosis was made, requesting information of the treatment and progression, when possible.
✓. Availability of clinical, epidemiological and progress data.

What they're measuring

Number of participants with breast cancer diagnosis during the gestation, breastfeeding, first year after the delivery (not during breastfeeding period), after a pregnancy and followed by any fertility preservation method before the anticancer treatment

Timeframe: Baseline visit

Race of participants with breast cancer diagnosis during the gestation, breastfeeding, first year after the delivery (not during breastfeeding period), after a pregnancy and followed by any fertility preservation method before the anticancer treatment

Timeframe: Baseline visit

Age of participants with breast cancer diagnosis during the gestation, breastfeeding, first year after the delivery (not during breastfeeding period), after a pregnancy and followed by any fertility preservation method before the anticancer treatment

Timeframe: Baseline visit

Trial details

NCT IDNCT04603820

SponsorSpanish Breast Cancer Research Group

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-01

View on ClinicalTrials.gov More Breast Cancer and Pregnancy trials

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The patient should have signed and dated the informed consent form (ICF). The enrollment of patients who have died is allowed.
✓. Women aged ≥ 18 years.
✓. Patients in one of the following situations:
✓. The patients referred to in the previous section and the patients who meet these characteristics prospectively could be enrolled retrospectively upon registry opening.
✓. All cases diagnosed at the same site may be included. In order to prevent duplications, in case the patient followed her treatment and follow-up at another site, she will be enrolled as per the site where the diagnosis was made, requesting information of the treatment and progression, when possible.
✓. Availability of clinical, epidemiological and progress data.

What they're measuring

Timeframe: Baseline visit